APOBEC (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "APOBEC" in English language version.

refsWebsite

Global rank English rank

10nih.gov

4^th place

8doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

1rcsb.org

8,838^th place

8,783^rd place

1harvard.edu

18^th place

17^th place

1sourceforge.net

1,669^th place

1,290^th place

1omim.org

4,380^th place

4,305^th place

1genengnews.com

low place

6,625^th place

1fz-juelich.de

low place

doi.org

PDB: 2NYT; Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS (January 2007). "The APOBEC-2 crystal structure and functional implications for the deaminase AID". Nature. 445 (7126): 447–451. Bibcode:2007Natur.445..447P. doi:10.1038/nature05492. PMID 17187054. S2CID 4394772.; rendered using PyMOL.
Wedekind JE, Dance GS, Sowden MP, Smith HC (April 2003). "Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business". Trends in Genetics. 19 (4): 207–216. doi:10.1016/S0168-9525(03)00054-4. PMID 12683974.
Blanc V, Davidson NO (January 2003). "C-to-U RNA editing: mechanisms leading to genetic diversity". The Journal of Biological Chemistry. 278 (3): 1395–1398. doi:10.1074/jbc.r200024200. PMID 12446660.
Cervantes-Gracia K, Gramalla-Schmitz A, Weischedel J, Chahwan R (November 2021). "APOBECs orchestrate genomic and epigenomic editing across health and disease". Trends in Genetics. 37 (11): 1028–1043. doi:10.1016/j.tig.2021.07.003. PMID 34353635. S2CID 236934922.
Koito A, Ikeda T (2013). "Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases". Frontiers in Microbiology. 4: 28. doi:10.3389/fmicb.2013.00028. PMC 3576619. PMID 23431045.
Butler K, Banday AR (March 2023). "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential". Journal of Hematology & Oncology. 16 (1): 31. doi:10.1186/s13045-023-01425-5. PMC 10044795. PMID 36978147.
Okazaki IM, Kotani A, Honjo T (2007-01-01). "Role of AID in tumorigenesis". AID for Immunoglobulin Diversity. Advances in Immunology. Vol. 94. Academic Press. pp. 245–273. doi:10.1016/s0065-2776(06)94008-5. ISBN 9780123737069. PMID 17560277.
Vasudevan AA, Smits SH, Höppner A, Häussinger D, Koenig BW, Münk C (November 2013). "Structural features of antiviral DNA cytidine deaminases" (PDF). Biological Chemistry. 394 (11): 1357–1370. doi:10.1515/hsz-2013-0165. PMID 23787464. S2CID 4151961.

fz-juelich.de

juser.fz-juelich.de

Vasudevan AA, Smits SH, Höppner A, Häussinger D, Koenig BW, Münk C (November 2013). "Structural features of antiviral DNA cytidine deaminases" (PDF). Biological Chemistry. 394 (11): 1357–1370. doi:10.1515/hsz-2013-0165. PMID 23787464. S2CID 4151961.

genengnews.com

"Unexpected DNA-Binding Mechanism Suggests Ways to Block Enzyme Activity in Cancer". Dec 2016. Based on ("Structural Basis for Targeted DNA Cytosine Deamination and Mutagenesis by APOBEC3A and APOBEC3B") online in Nature Structural and Molecular Biology.

harvard.edu

ui.adsabs.harvard.edu

PDB: 2NYT; Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS (January 2007). "The APOBEC-2 crystal structure and functional implications for the deaminase AID". Nature. 445 (7126): 447–451. Bibcode:2007Natur.445..447P. doi:10.1038/nature05492. PMID 17187054. S2CID 4394772.; rendered using PyMOL.

nih.gov

pubmed.ncbi.nlm.nih.gov

PDB: 2NYT; Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS (January 2007). "The APOBEC-2 crystal structure and functional implications for the deaminase AID". Nature. 445 (7126): 447–451. Bibcode:2007Natur.445..447P. doi:10.1038/nature05492. PMID 17187054. S2CID 4394772.; rendered using PyMOL.
Wedekind JE, Dance GS, Sowden MP, Smith HC (April 2003). "Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business". Trends in Genetics. 19 (4): 207–216. doi:10.1016/S0168-9525(03)00054-4. PMID 12683974.
Blanc V, Davidson NO (January 2003). "C-to-U RNA editing: mechanisms leading to genetic diversity". The Journal of Biological Chemistry. 278 (3): 1395–1398. doi:10.1074/jbc.r200024200. PMID 12446660.
Cervantes-Gracia K, Gramalla-Schmitz A, Weischedel J, Chahwan R (November 2021). "APOBECs orchestrate genomic and epigenomic editing across health and disease". Trends in Genetics. 37 (11): 1028–1043. doi:10.1016/j.tig.2021.07.003. PMID 34353635. S2CID 236934922.
Koito A, Ikeda T (2013). "Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases". Frontiers in Microbiology. 4: 28. doi:10.3389/fmicb.2013.00028. PMC 3576619. PMID 23431045.
Butler K, Banday AR (March 2023). "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential". Journal of Hematology & Oncology. 16 (1): 31. doi:10.1186/s13045-023-01425-5. PMC 10044795. PMID 36978147.
Okazaki IM, Kotani A, Honjo T (2007-01-01). "Role of AID in tumorigenesis". AID for Immunoglobulin Diversity. Advances in Immunology. Vol. 94. Academic Press. pp. 245–273. doi:10.1016/s0065-2776(06)94008-5. ISBN 9780123737069. PMID 17560277.
Vasudevan AA, Smits SH, Höppner A, Häussinger D, Koenig BW, Münk C (November 2013). "Structural features of antiviral DNA cytidine deaminases" (PDF). Biological Chemistry. 394 (11): 1357–1370. doi:10.1515/hsz-2013-0165. PMID 23787464. S2CID 4151961.

ncbi.nlm.nih.gov

Koito A, Ikeda T (2013). "Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases". Frontiers in Microbiology. 4: 28. doi:10.3389/fmicb.2013.00028. PMC 3576619. PMID 23431045.
Butler K, Banday AR (March 2023). "APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential". Journal of Hematology & Oncology. 16 (1): 31. doi:10.1186/s13045-023-01425-5. PMC 10044795. PMID 36978147.

omim.org

McKusick VA, Hamosh A (19 December 2019) [Originally published 27 September 1994]. "APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE 1; APOBEC1". Online Mendelian Inheritance in Man. Retrieved 23 December 2023.

rcsb.org

PDB: 2NYT; Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS (January 2007). "The APOBEC-2 crystal structure and functional implications for the deaminase AID". Nature. 445 (7126): 447–451. Bibcode:2007Natur.445..447P. doi:10.1038/nature05492. PMID 17187054. S2CID 4394772.; rendered using PyMOL.

semanticscholar.org

api.semanticscholar.org

PDB: 2NYT; Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS (January 2007). "The APOBEC-2 crystal structure and functional implications for the deaminase AID". Nature. 445 (7126): 447–451. Bibcode:2007Natur.445..447P. doi:10.1038/nature05492. PMID 17187054. S2CID 4394772.; rendered using PyMOL.
Cervantes-Gracia K, Gramalla-Schmitz A, Weischedel J, Chahwan R (November 2021). "APOBECs orchestrate genomic and epigenomic editing across health and disease". Trends in Genetics. 37 (11): 1028–1043. doi:10.1016/j.tig.2021.07.003. PMID 34353635. S2CID 236934922.
Vasudevan AA, Smits SH, Höppner A, Häussinger D, Koenig BW, Münk C (November 2013). "Structural features of antiviral DNA cytidine deaminases" (PDF). Biological Chemistry. 394 (11): 1357–1370. doi:10.1515/hsz-2013-0165. PMID 23787464. S2CID 4151961.

sourceforge.net

pymol.sourceforge.net

PDB: 2NYT; Prochnow C, Bransteitter R, Klein MG, Goodman MF, Chen XS (January 2007). "The APOBEC-2 crystal structure and functional implications for the deaminase AID". Nature. 445 (7126): 447–451. Bibcode:2007Natur.445..447P. doi:10.1038/nature05492. PMID 17187054. S2CID 4394772.; rendered using PyMOL.